QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
QQQ   279.76 (-0.79%)
AAPL   145.43 (-0.66%)
MSFT   246.79 (-0.97%)
META   139.07 (+0.06%)
GOOGL   101.42 (+-0.01%)
AMZN   120.30 (-0.54%)
TSLA   238.13 (-1.11%)
NVDA   131.30 (-0.60%)
NIO   14.77 (-7.92%)
BABA   84.32 (-0.08%)
AMD   67.85 (-0.13%)
T   15.32 (-3.83%)
MU   54.62 (-0.20%)
CGC   3.75 (+22.15%)
F   12.36 (-1.20%)
GE   66.22 (-1.81%)
DIS   100.04 (-0.75%)
AMC   7.12 (-2.86%)
PYPL   94.42 (+0.63%)
PFE   43.09 (-2.33%)
NFLX   240.02 (+1.39%)
NASDAQ:APYX

Apyx Medical - APYX Stock Forecast, Price & News

$4.72
-0.15 (-3.08%)
(As of 10/6/2022 12:00 AM ET)
Add
Compare
Today's Range
$4.69
$4.96
50-Day Range
$4.49
$10.83
52-Week Range
$3.01
$17.50
Volume
48,613 shs
Average Volume
342,522 shs
Market Capitalization
$163.18 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$15.33

Apyx Medical MarketRank™ Forecast

Analyst Rating
Buy
3.00 Rating Score
Upside/​Downside
224.9% Upside
$15.33 Price Target
Short Interest
Healthy
1.57% of Float Sold Short
Dividend Strength
N/A
Sustainability
-0.96
Upright™ Environmental Score
News Sentiment
N/A
Insider Trading
Acquiring Shares
$70,030 Bought Last Quarter
Proj. Earnings Growth
Growing
From ($0.52) to ($0.43) Per Share

Overall MarketRank

MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.

2.62 out of 5 stars

Medical Sector

94th out of 1,075 stocks

Surgical & Medical Instruments Industry

9th out of 104 stocks

APYX stock logo

About Apyx Medical (NASDAQ:APYX) Stock

Apyx Medical Corporation, an energy technology company, develops, manufactures, and sells medical devices in the cosmetic and surgical markets worldwide. The company operates in two segments, Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium to cut, coagulate and ablate soft tissue during open and laparoscopic surgical procedures. The company offers Renuvion branded products for the cosmetic surgery market that enable plastic surgeons, fascial plastic surgeons, and cosmetic physicians to provide controlled heat to the tissue to achieve their desired results; and J-Plasma branded products for the hospital surgical market. It also develops, manufactures, and sells disposable hand pieces, and OEM generators and accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.

Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Stock News Headlines

4APYX : Apyx Medical: Q2 Earnings Insights
See More Headlines
Receive APYX Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Apyx Medical and its competitors with MarketBeat's FREE daily newsletter.

APYX Company Calendar

Last Earnings
8/11/2022
Today
10/06/2022
Next Earnings (Confirmed)
11/10/2022
Fiscal Year End
12/31/2022

Industry, Sector and Symbol

Industry
Surgical & medical instruments
Sub-Industry
N/A
Sector
Medical
Current Symbol
NASDAQ:APYX
Employees
272
Year Founded
N/A

Price Target and Rating

Average Stock Price Forecast
$15.33
High Stock Price Forecast
$17.00
Low Stock Price Forecast
$12.00
Forecasted Upside/Downside
+224.9%
Consensus Rating
Buy
Rating Score (0-4)
3.00
Research Coverage
4 Analysts

Profitability

Net Income
$-15,170,000.00
Pretax Margin
-33.61%

Debt

Sales & Book Value

Annual Sales
$48.52 million
Book Value
$1.57 per share

Miscellaneous

Free Float
30,563,000
Market Cap
$163.18 million
Optionable
Optionable
Beta
1.54

Key Executives

  • Mr. Charles D. Goodwin II (Age 56)
    Pres, CEO & Director
    Comp: $892.97k
  • Ms. Tara H. Semb (Age 52)
    CFO, Treasurer & Sec.
    Comp: $531.67k
  • Mr. Moshe Citronowicz (Age 69)
    Sr. VP
    Comp: $432.49k
  • Mr. Todd Hornsby (Age 46)
    Exec. VP
    Comp: $590.66k













APYX Stock - Frequently Asked Questions

Should I buy or sell Apyx Medical stock right now?

4 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Apyx Medical in the last twelve months. There are currently 4 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "buy" APYX shares.
View APYX analyst ratings
or view top-rated stocks.

What is Apyx Medical's stock price forecast for 2022?

4 equities research analysts have issued 12 month price targets for Apyx Medical's stock. Their APYX share price forecasts range from $12.00 to $17.00. On average, they anticipate the company's stock price to reach $15.33 in the next year. This suggests a possible upside of 224.9% from the stock's current price.
View analysts price targets for APYX
or view top-rated stocks among Wall Street analysts.

How have APYX shares performed in 2022?

Apyx Medical's stock was trading at $12.82 at the beginning of the year. Since then, APYX stock has decreased by 63.2% and is now trading at $4.72.
View the best growth stocks for 2022 here
.

When is Apyx Medical's next earnings date?

The company is scheduled to release its next quarterly earnings announcement on Thursday, November 10th 2022.
View our APYX earnings forecast
.

How can I listen to Apyx Medical's earnings call?

Apyx Medical will be holding an earnings conference call on Thursday, November 10th at 8:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at 201-612-7415 with passcode "13733047".

How were Apyx Medical's earnings last quarter?

Apyx Medical Co. (NASDAQ:APYX) posted its earnings results on Thursday, August, 11th. The company reported ($0.16) EPS for the quarter, beating analysts' consensus estimates of ($0.20) by $0.04. The company had revenue of $10.29 million for the quarter, compared to the consensus estimate of $10.66 million. Apyx Medical had a negative trailing twelve-month return on equity of 34.39% and a negative net margin of 34.21%. During the same period last year, the business posted ($0.12) EPS.

What guidance has Apyx Medical issued on next quarter's earnings?

Apyx Medical updated its FY 2022 earnings guidance on Friday, September, 9th. The company provided EPS guidance of for the period. The company issued revenue guidance of $51.00 million-$56.40 million, compared to the consensus revenue estimate of $55.88 million.

What other stocks do shareholders of Apyx Medical own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Apyx Medical investors own include Main Street Capital (MAIN), Johnson & Johnson (JNJ), ONEOK (OKE), Occidental Petroleum (OXY), Procter & Gamble (PG), STORE Capital (STOR), Wells Fargo & Company (WFC), Boeing (BA), Bank of America (BAC) and Delta Air Lines (DAL).

What is Apyx Medical's stock symbol?

Apyx Medical trades on the NASDAQ under the ticker symbol "APYX."

How do I buy shares of Apyx Medical?

Shares of APYX stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Apyx Medical's stock price today?

One share of APYX stock can currently be purchased for approximately $4.72.

How much money does Apyx Medical make?

Apyx Medical (NASDAQ:APYX) has a market capitalization of $163.18 million and generates $48.52 million in revenue each year. The company earns $-15,170,000.00 in net income (profit) each year or ($0.51) on an earnings per share basis.

How many employees does Apyx Medical have?

The company employs 272 workers across the globe.

How can I contact Apyx Medical?

Apyx Medical's mailing address is 5115 Ulmerton Road, Clearwater FL, 33760. The official website for the company is www.apyxmedical.com. The company can be reached via phone at (727) 384-2323, via email at investor.relations@apyxmedical.com, or via fax at 800-323-1640.

This page (NASDAQ:APYX) was last updated on 10/6/2022 by MarketBeat.com Staff

MarketBeat Resources

Premium Research Tools

MarketBeat All Access members have access to premium reports, best-in-class portfolio monitoring tools, and our latest stock picks.

Discover All Access

Market Data and Calendars

Looking for new stock ideas? Want to see which stocks are moving? View our full suite of financial calendars and market data tables, all for free.

View Market Data

Investing Education and Resources

Receive a free world-class investing education from MarketBeat. Learn about financial terms, types of investments, trading strategies, and more.

Financial Terms
Details Here
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau MarketBeat is rated as Great on TrustPilot

© American Consumer News, LLC dba MarketBeat® 2010-2022. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | contact@marketbeat.com | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Privacy Policy | Do Not Sell My Information | RSS Feeds

© 2022 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see Barchart's disclaimer.